Fibrotic effects and regulation of MMP proteins in thrombus resolution
Fibrotic effects and regulation of MMP proteins in thrombus resolution
批准号:
7464343
负责人:
RAJABRATA SARKAR
金额:
$8.83万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-12 至 2010-03-31
关键词:
Adenovirus VectorAffectAmericanBiological AssayBiomechanicsBlood ClotBlood VesselsBlood coagulationChronicCicatrixCoagulation ProcessCollagenDeep Vein ThrombosisDevelopmentDisease regressionElasticityEnd PointEndopeptidasesEndothelial CellsEnzymesEssential GenesEventFibrosisFunctional disorderGelatinase AGelatinase BGenesGenetic TranscriptionHumanInterstitial CollagenaseKnowledgeLeadLegLocalizedMatrix MetalloproteinasesMetalloproteinase GeneMolecularMusObstructionPainPain in lower limbPathogenesisPatientsPatternPeptide HydrolasesPlayPostphlebitic SyndromeProcessProtein IsoformsProtein OverexpressionProteinsRegulationReporterResearch PersonnelResearch ProposalsResolutionRoleSeriesSkinSmooth Muscle MyocytesSwellingTestingThrombophlebitisThrombusTissuesTransgenic OrganismsUlcerVeinsVenousactivating transcription factorcell motilitycell typechromatin immunoprecipitationclinically significanthuman MMP14 proteinmonocytemouse modelnovelpreventprogramsresearch studytranscription factor
中文摘要
深静脉血栓形成(DVT)每年影响200多万美国人。静脉炎后综合征
可影响25%-75%的DVT患者,包括腿部肿胀、疼痛、皮肤变化和溃疡
皮肤。这只发生在DVT患者的一小部分中,这表明血栓溶解在
确定慢性静脉阻塞和纤维化是否会发展并导致静脉炎后
综合症。基质金属蛋白酶(MMP)基因对细胞迁移和组织重塑至关重要
在血栓溶解过程中表达和激活,表明在这一过程中起着关键作用。他们在其中扮演的角色
静脉炎后综合征的发病机制有三个具体的目的:1)定义
血栓诱导的基质金属蛋白酶-2基因及其同源转录因子的区域
2)检测MMP2、MMP9和MMP14(MT-MMPf)在DVT消退中的作用;
血栓诱导的静脉壁纤维化,3)确定基质金属蛋白酶蛋白(基质金属蛋白酶-2、基质金属蛋白酶-9)是否过表达
和基质金属蛋白酶-14)加速DVT的分解,并改变血栓诱导的静脉壁纤维化。一系列独特的
将使用转基因的基质金属蛋白酶-2报告小鼠来确定基质金属蛋白酶-2基因的哪些区域是必需的
对于血栓诱导的基质金属蛋白酶-2转录和染色质免疫沉淀将用于鉴定
同源转录因子。靶向缺失各种基质金属蛋白酶基因的小鼠将被用来确定
这些酶在血栓再通、静脉壁纤维化和静脉壁顺应性丧失中的作用
使用新的小鼠静脉生物力学分析方法的弹性。组织特异性转基因过表达
基质金属蛋白酶-2、-14和-9以及编码这些异构体的腺病毒载体将被用来过表达
这些蛋白质在血栓溶解过程中决定了DVT的溶解速度是加速的,并且对
纤维化和静脉壁的生物力学。这些研究将确定基质金属蛋白酶蛋白在有益和
血栓溶解的不利方面,并表征潜在的分子治疗以防止后
静脉炎综合征。
相关性:这项提议将确定基质金属蛋白酶蛋白如何导致瘢痕形成和
血液凝块后血管变厚,这会导致后来的腿部疼痛、肿胀和溃疡。这些研究将
增加关于血栓如何损害静脉的知识,并测试新的治疗方法以防止这种损害。
英文摘要
Deep venous thrombosis (DVT) affects more than 2 million Americans per year. Post-phlebitic syndrome
can affect 25-75% of patients following DVT and includes leg swelling, pain, skin changes and ulceration of
the skin. This develops only in a subset of DVT patients, suggesting that thrombus resolution is critical in
determining whether chronic venous obstruction and fibrosis will develop and lead to post-phlebitic
syndrome. Matrix metalloproteinase (MMP) genes, critical to cell migration and tissue remodeling, are
expressed and activated during thrombus resolution suggesting a critical role in this process. Their role in
the pathogenesis of post-phlebitic syndrome will be defined with three Specific Aims: 1) To define the
regions of the MMP-2 gene and cognate transcription factors critical to thrombus-induced MMP-2
expression, 2) To determine the role of MMP-2, MMP-9 and MMP-14 (MT-MMP-f) in DVT resolution and
thrombus-induced vein wall fibrosis, 3) To determine if overexpression of MMP proteins (MMP-2, MMP-9
and MMP-14) accelerates DVT resolution and alters thrombus-induced vein wall fibrosis. A unique series of
transgenic MMP-2 reporter mice will be used to determine which regions of the MMP-2 gene are essential
for thrombus-induced MMP-2 transcription and chromatin immunoprecipitation will be used to identity the
cognate transcription factors. Mice with targeted deletion of various MMP genes will be used to determine
the role of these enzymes in thrombus recanalization, vein wall fibrosis and loss of vein wall compliance and
elasticity using novel assays of mouse vein biomechanics.Tissue-specific transgenic overexpression of
MMP-2, -14 and -9 as well as adenoviral vectors encoding these isoforms will be utilized to overexpress
these proteins during thrombus resolution to determine resolution of DVT is accelerated and the effects on
fibrosis and vein wall biomechanics.These studies will define the role of MMP proteins in the beneficial and
detrimental aspects of thrombus resolution, and characterize potential molecular therapy to prevent post-
phlebitic syndrome.
RELEVANCE: This proposalwill determine how matrix metalloproteinase proteins cause scarring and
thickening of veins after blood clots, which can cause later leg pain, swelling and ulcers. These studies will
increase knowledge of how veins are damaged by clots and test new treatments to prevent this damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The effect of Myristolated alanine-rich C Kinase Substrate (MARCKS) on kinase interacting with stathmin (KIS) in differential proliferation of vascular smooth muscle and endothelial cells
-
批准号:10198997
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2017
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7071000
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7613397
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7236604
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7032907
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7179336
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7392800
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7996428
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7365275
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7790670
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6189900
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6619798
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6388687
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6526591
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6779743
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
EFFECT OF RECOMBINANT TPA GENE EXPRESSION IN ENDOTHELIUM
-
批准号:2213453
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1994
-
负责人:RAJABRATA SARKAR
-
依托单位:
EFFECT OF RECOMBINANT TPA GENE EXPRESSION IN ENDOTHELIUM
-
批准号:3052057
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1992
-
负责人:RAJABRATA SARKAR
-
依托单位:
海外基金